All planned clinical trials for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) wet AMD BLA now fully...
Therapeutics
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2020 Nasdaq: NBSE
(MENAFN – GlobeNewsWire – Nasdaq) Data presented throughout 2020 have validated the potential of...
Data presented throughout 2020 have validated the potential of the PATrOL™ platform to develop...
ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company primarily focused...
For Immediate Release Chicago, IL – December 21, 2020 – Zacks.com announces the record...
The MarketWatch News Section was not included in the creation of this information. BEDMINSTER,...
WARREN, N.J., Dec. 16, 2020 (World NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a...